Maternal Diabetes in Newborns With Hearing Loss

Study Overview
=================
Brief Summary
-----------------
This study aims to investigate the presence and characteristics of maternal diabetes as a risk factor in newborns with hearing loss. Hearing loss is one of the most common congenital anomalies among newborns. The newborn hearing screening program is important for early diagnosis in newborns with hearing loss.Gestational diabetes, on the other hand, is a metabolic disease that occurs during pregnancy and can cause complications as in other diabetes mellitus patients. Despite our knowledge of major complications, the effect of the hyperglycemic intrauterine environment on hearing outcomes has not been adequately studied. The inner ear does not store energy, so it has a particularly high sensitivity to altered blood sugar and insulin. Altered inner ear metabolism leads to auditory and balance disorders. There is no study in the literature comparing uncomplicated gestational diabetes and pregestational diabetes as a prenatal complication that poses a risk of hearing loss.

Official Title
-----------------
Newborn Hearing Loss

Conditions
-----------------
Gestational Diabetes, Pregestational Diabetes, Hearing Loss

Intervention / Treatment
-----------------
* Diagnostic Test: hearing test


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: POSTNATAL AGE BETWEEN 0-28 DAYS BIRTH WEIGHT ≥2000GR TO HAVE TESTED ON THE NEWBORN HEARING SCREENING UNIT AT ANKARA CITY HOSPITAL Exclusion Criteria: PRETERMS CRANIOFACIAL ANOMALIES INTRAUTERINE INFECTIONS BIRTH WEIGHT <2000 GR

Ages Eligible for Study
-----------------
Minimum Age: 1 Day
Maximum Age: 28 Days

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| gestational diabetic mother<br>Hearing tests of the babies of pregnant women who are being followed up with the diagnosis of gestational diabetes in the peritanotogy clinic | Diagnostic Test: hearing test<br>* Auditory Brainstem Response (ABR) Test<br>* Other names: ABR;|
| pregestational diabetic mother<br>Hearing tests of the babies of pregnant women who are being followed up with the diagnosis of pregestational diabetes in the peritanotogy clinic | Diagnostic Test: hearing test<br>* Auditory Brainstem Response (ABR) Test<br>* Other names: ABR;|
| non diabetic mother<br>Hearing tests of babies whose mothers do not have gestational or pregestational diabetes | Diagnostic Test: hearing test<br>* Auditory Brainstem Response (ABR) Test<br>* Other names: ABR;|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Hearing Loss | Hearing test results in babies with no diabetes, pregestational diabetes, and gestational diabetes | 6 months | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| diabetic mother | Evaluation of classification tests by separating them from subgroups according to mothers' control times, usage controls, and glycemic viewers | 6 months |